Ultromics raises $55M Series C to scale AI -driven heart failure detection - Tech.eu
Ultromics has developed the first FDA-cleared, Medicare-reimbursed AI technology designed to help clinicians detect Heart Failure with Preserved ...
Read the original at Tech.eu ↗
- Topics
- Markets & InvestmentHealthcare
- Mentions
- FDA
- Tracked via
- “AI Falures”
Same story, other outlets
- Ultromics Lands $55M Series C to Tackle Undiagnosed Heart Failure at Scale PR Newswire · Jul 31, 2025